Australia's most trusted
source of pharma news
Tuesday, 03 February 2026
Tuesday, 3 February 2026
Subscribe
Login
News Headlines
News Headlines
News
Bracing for a $100M revenue hit
Posted 24 July 2024 AM
By the end of July a $397 million blockbuster will be off patent in Australia, and the first biosimilar is primed for launch.
Johnson & Johnson's monoclonal antibody Stelara is set to lose patent protection in Australia on 28 July, mirroring the loss of exclusivity in Europe where the pharma giant expects to greet biosimilar competition in the last week of the month. Although its US patents expired last year, as a result of settlements and agreements J&J does not expect competition in that country until the start of 2025.
To see the whole article, please login
Posted 24 July 2024 AM
By the end of July a $397 million blockbuster will be off patent in Australia, and the first biosimilar is primed for launch.
Johnson & Johnson's monoclonal antibody Stelara is set to lose patent protection in Australia on 28 July, mirroring the loss of exclusivity in Europe where the pharma giant expects to greet biosimilar competition in the last week of the month. Although its US patents expired last year, as a result of settlements and agreements J&J does not expect competition in that country until the start of 2025.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (16)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
- Senior Territory Sales Manager - Melbourne
- Customer Service Representative - Pemulwuy
- Sales & Key Account Associate - Melbourne
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- Pharmaceutical Sales Representative - Gold Coast
- GP Sales Representative - Brisbane
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Pharmaceutical Sales Representative - Sydney
- Customer Service Specialist - Frenchs Forest
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (7)
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Clinical Research, Business Development Manager - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (5)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Other (18)
- Distribution and Warehouse Technician - Broadmeadows
- Recruitment Consultant - Sydney
- Logistics Specialist - Macquarie Park
- Warehouse Associate - Chatswood
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- Warehouse & Logistics Officer - Macquarie Park
- GP Rep Bundaberg Contract - Bundaberg
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
- Materials Planner - North Ryde
- Senior Recruitment Consultant - Sydney
- Warehouse Coordinator - Alexandria
- HR Analyst (Workday Specialist) - Melbourne
- Senior Recruitment Consultant - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.